NCT07072286 RELIEVED (REgionaL anesthesIa PElVic fracturEs stuDy) Study. Regional Anesthesia (RA) Techniques for Pain Management in Pelvic Fractures: A Prospective, Monocentric, Pilot Cohort Study.
| NCT ID | NCT07072286 |
| Status | Recruiting |
| Phase | — |
| Sponsor | A.O.U. Città della Salute e della Scienza |
| Condition | Pelvic Bone Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 177 participants |
| Start Date | 2024-07-25 |
| Primary Completion | 2026-10-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 177 participants in total. It began in 2024-07-25 with a primary completion date of 2026-10-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational clinical trial is to assess the impact of Regional Anesthesia (RA) techniques with the strongest anatomical and scientific support in controlling acute post-operative pain in pelvic/acetabular fractures, as well as their potential role in reducing complications related to excessive intra- and postoperative opioid use. The main questions it aims to answer are: Does RA lower opioid use in the first 24 hours after pelvic/acetabular fractures surgery? Does RA lower pain scores in the first 48 hours after surgery, incidence of complications and occurrence of persistent post-surgical pain? During the hours and days following surgery, the research team will evaluate and assess the intensity of any postoperative pain at predefined time points; quantify the use of pain medications and any related complications; and measure the possible onset of chronic pain and the timeline of functional recovery (through scheduled clinical follow-up at 30, 60, and 90 days). Participants will: at the time of surgery, and only in the presence of trained and certified anesthesiologists, patients will receive regional anesthesia techniques in addition to the standard multimodal analgesic treatment. In the absence of certified anesthesiologists, patients will be treated exclusively with systemic multimodal analgesia according to the standard protocol. All the procedures are part of the current clinical practice and no experimental techniques or medications are involved.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years and ability to provide informed consent * Patients with pelvic/acetabular fractures requiring surgery Exclusion Criteria * Age \< 18 years * Absolute contraindications to ALR techniques (uncorrectable coagulopathies, known allergy to local anesthetics, technical impossibility of execution)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07072286 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pelvic Bone Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07072286 currently recruiting?
Yes, NCT07072286 is actively recruiting participants. Contact the research team at marco.ulla@gmail.com for enrollment information.
Where is the NCT07072286 trial being conducted?
This trial is being conducted at Turin, Italy.
Who is sponsoring the NCT07072286 clinical trial?
NCT07072286 is sponsored by A.O.U. Città della Salute e della Scienza. The trial plans to enroll 177 participants.